JACOBS LEVY EQUITY MANAGEMENT, INC

Position in SEER — Seer, Inc.

CIK 884414 FLORHAM PARK, NJ

Position in SEER

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$369,071

+$128,425 QoQ

Shares Held

222,332

+55.2% QoQ

Ownership

0.402%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#15

of 59 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JACOBS LEVY EQUITY MANAGEMENT, INC holds $740,535,030 across 80 Biotechnology names. SEER ranks #69 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	256,503	$159,939,880
2	RARE	Ultragenyx Pharmaceutical Inc.	2,939,719	$98,157,217
3	INCY	Incyte Corp	731,774	$82,953,900
4	CORT	Corcept Therapeutics Inc	695,532	$60,476,507
5	HALO	Halozyme Therapeutics, Inc.	322,377	$25,232,447
6	EXEL	Exelixis, Inc.	415,650	$22,615,516
7	AUPH	Aurinia Pharmaceuticals Inc.	1,231,516	$20,898,826
8	ALNY	Alnylam Pharmaceuticals, Inc.	60,986	$18,358,615

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$369,071	222,332	+55.2%	Shares	Sole	2026-08-14
2026-03-31	$240,646	143,242	+267.1%	Shares	Sole	2026-05-15
2025-12-31	$71,399	39,016	-65.3%	Shares	Sole	2026-02-13
2025-09-30	$244,244	112,555	-65.6%	Shares	Sole	2025-11-17
2025-06-30	$700,650	327,407	-9.9%	Shares	Sole	2025-08-14
2025-03-31	$614,069	363,355	+124.5%	Shares	Sole	2025-05-15
2024-12-31	$373,905	161,864	-63.7%	Shares	Sole	2025-02-14
2024-09-30	$877,867	445,618	-4.2%	Shares	Sole	2024-11-14
2024-06-30	$781,188	464,993	-1.3%	Shares	Sole	2024-08-14
2024-03-31	$895,120	471,116	-4.9%	Shares	Sole	2024-05-15
2023-12-31	$960,581	495,145	+42.5%	Shares	Sole	2024-02-14
2023-09-30	$767,685	347,369	-0.3%	Shares	Sole	2023-11-17
2023-06-30	$1,488,368	348,564	-22.0%	Shares	Sole	2023-08-14
2023-03-31	$1,725,670	447,065	—	Shares	Sole	2023-05-15
No filing history on record for this holder in this stock.